This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Castillo, J. Articles by Noya, M. Search for Related Content PubMed PubMed Citation Articles by Castillo, J. Articles by Noya, M. Pubmed/NCBI databases Medline Plus Health Information Headache

(Stroke. 1995;26:2035-2039.)
© 1995 American Heart Association, Inc.

Articles

Amino Acid Transmitters in Patients With Headache During the Acute Phase of Cerebrovascular Ischemic Disease

J. Castillo, MD; F. Martínez, MD; E. Corredera, MD; J.M. Aldrey, MD M. Noya, MD

From the Neurology Department, Hospital General de Galicia, Clínico Universitario, Santiago de Compostela, Spain.

Correspondence to José Castillo, MD, Servicio de Neurología, Hospital General de Galicia, Santiago de Compostela, Spain.

Background and Purpose The pathophysiology of headache occurring at stroke onset is unknown. Migraine and ischemia share an excessive release of neuroexcitatory amino acids. Inhibitory amino acids also may be implicated in both diseases. We investigated whether fluctuations of these amino acids occur in headache accompanying cerebral infarction.

Methods We studied 100 patients with infarction in the territory of the middle cerebral artery. Neurological impairment was assessed using the Canadian Neurological Scale and Barthel Index. Size of infarction was determined with CT. Twenty-eight patients developed headache. Glutamate, aspartate, and taurine were quantified in blood and cerebrospinal fluid (CSF) within 24 hours of stroke onset with cationic exchange chromatography.

Results Stroke subtypes, size of infarct on CT, and clinical scales were similar in patients with and without headache. Plasma glutamate level was 321.14±149.53 µmol/L in patients with headache and 233±107.23 µmol/L in those without headache (P<.005). Glutamate in CSF was higher in patients with headache (4.6±1.49 µmol/L) than in patients without headache (3.11±1.18 µmol/L) (P<.001). Aspartate concentrations in plasma and CSF were similar in both groups. Taurine concentrations in plasma were 103.10±52.82 µmol/L and 177.49±90.92 µmol/L in headache and nonheadache patients, respectively (P<.001). Taurine levels in CSF were 5.42±2.42 µmol/L in patients with headache and 9.27±5.31 µmol/L in those without headache (P<.001). No significant correlation was found between amino acid levels in plasma or CSF and size of infarction.

Conclusions Amino acid neurotransmitters play a role in the pathophysiology of headache that occurs at the onset of stroke. The ischemic penumbral area, more than the infarction itself, may cause a state of cortical hyperexcitability that would be responsible for the cortical release of amino acids and the induction of headache by altering pain perception mechanisms.

Key Words: glutamates • cerebral ischemia • amino acids, neurotransmitter • headache

This article has been cited by other articles:

				M.-M. Hsu, Y.-Y. Chou, Y.-C. Chang, T.-C. Chou, and C.-S. Wong An Analysis of Excitatory Amino Acids, Nitric Oxide, and Prostaglandin E2 in the Cerebrospinal Fluid of Pregnant Women: The Effect on Labor Pain Anesth. Analg., November 1, 2001; 93(5): 1293 - 1296. [Abstract] [Full Text] [PDF]